FdaApplication
NDA 020131
Identifiers
- fda_app_no: NDA020131
Properties
| Property | Value |
|---|---|
| applicant_name | BRACCO DIAGNOSTICS INC |
| application_type | NDA |
| approval_date | 1992-11-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PROHANCE | GADOTERIDOL | 279.3MG/ML | INJECTABLE;INJECTION |
1 product